help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shortridge, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shortridge, K. F.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1416-1420, (2003)
© 2003 American Thoracic Society


Pulmonary Perspective

Severe Acute Respiratory Syndrome and Influenza

Virus Incursions from Southern China

Kennedy F. Shortridge

Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China

Correspondence and requests for reprints should be addressed to Kennedy F. Shortridge, Ph.D., Emeritus Professor, Department of Microbiology, The University of Hong Kong, University Pathology Building, Queen Mary Hospital, Pokfulam Road, Hong Kong SAR, China. E-mail: kennedyfs{at}xtra.co.nz

Only when we are at peace with nature will disease begin to melt away.

The eminent sinologist and historian, Joseph Needham, writing with his colleague Lu Gwei-Djen in the sixth volume of his mighty tome "Science and Civilization in China," emphasized the long held Chinese conviction that "the best medicine is preventive medicine," a conviction that goes back to the Warring States period (475–221 B.C.) when there was a flowering of philosophy and medical understanding. A Han Dynasty (206 B.C.–220 A.D.) writing concludes "A skillful doctor cures illness when there is no sign of disease, and thus the disease never comes" (1, 2). This component of the "Chinese Hippocratic Corpus," as Needham calls it, holds just as true in today's modern world and may be simply summed-up in one word: "awareness." In the case of emerging infectious disease, this means "preparedness," giving rise to "reaction."

Two thousand or so years onward in the China of today, this conviction is being sorely tested by nature with incursions of respiratory viruses from its southeastern province of Guangdong adjacent to Hong Kong. In 1997, the world was thrown into a state of alarm and high alert arising from the emergence of a potentially new influenza pandemic caused by the transmission of a highly pathogenic H5N1 influenza virus (H5N1/97) of avian origin from chickens to humans in Hong Kong (35). On that occasion, a pandemic was only one or two mutational events away. H5N1-like viruses were recognized in chicken and other land-based poultry in Hong Kong in 2001 and 2002 before they could infect humans (6, 7). Probably three or four mutational events from generating a pandemic influenza virus, these more recent incidents upheld the ancient ideal of preventing disease before it appears. In these cases the virus did not "escape" from Hong Kong almost certainly because of its having had sound human and animal disease and virus surveillance systems in place for some time. This led to the recognition of the source of the virus and its removal by the slaughter of poultry in live markets and on farms, or a combination of slaughter and ring vaccination on farms (68).

Over the years, Hong Kong essentially functioned as an influenza sentinel post for the wider region, stemming from the hypothesis that southern China is an epicenter for the emergence of pandemic influenza viruses (9). This hypothesis drew its strength from an earlier hypothesis generated from the 1968 H3N2 (Hong Kong) pandemic virus that pandemic influenza viruses have an animal origin (10). Consequently, a blueprint evolved to provide baseline preparedness at the human–animal interface in the epicenter for an inevitable influenza pandemic (11). The lack of signals indicating the emergence of the 1968 pandemic prompted Stuart-Harris to write soon after "Those who have spent their lives in attempts to further the conquest of infectious disease are humiliated by the contrast between the success of the astronauts and the failure to control acute respiratory disease" (12). Understanding animals and the ecology of their viruses might prove to be a positive, if not decisive, contribution in dealing with known and yet-to-be-revealed zoonotic situations.

In mid- to late-February 2003, the alarm of 1997 verged on panic in some areas of the world after the international seeding by air travel of a hitherto unrecognized coronavirus (SCoV), possibly of animal origin, which was isolated in Hong Kong from cases of severe atypical pneumonia (13). The disease was designated severe acute respiratory syndrome, or SARS (14), coming on the heels of an outbreak of severe atypical pneumonia with a reported case fatality rate around 4% some 3 months earlier in Guangdong Province (15). These circumstances, along with the clinical similarity between H5N1 "bird flu" and SARS (13), triggered the World Health Organization (WHO) Global Influenza Surveillance Network's reaction against SARS (16) in a manner befitting a newly emerging pandemic influenza virus. All the more so since the SCoV originated in the pandemic influenza epicenter as had the influenza H5N1/97 virus previously (4, 8) leading to a new level of international cooperation and collaboration within and outside the Network (16, 17) to stem the further spread of SARS. This splendid interaction gave rise to a series of reports confirming the isolation of a novel coronavirus from SARS patients from a number of centers (e.g., 1821), wider aspects of the disease, its epidemiology, and its transmission (e.g., 2224).

While many experts were primed for dealing with this new-found situation, the WHO played a leadership role in coordinating the multilevel activities involved. National health authorities in 30 countries reporting SARS cases reacted vigorously in their control measures (25), and in early July, WHO declared that the SARS outbreak had been contained worldwide (26); a great achievement. The virus had been dealt with decisively at the many focal points around the globe. Nonetheless, WHO issued a caveat of the need for continued vigilance worldwide for the possible reemergence of SARS (27) arising from, say, previously undetected, long-term carriers or fresh infections arising from contact with infected animals.

Because the earliest SARS cases in Guangdong Province reportedly occurred in restaurant workers handling wild animals as exotic food (28), and early phylogenetic analysis indicated that the SCoV was of novel zoonotic origin (13), wild mammals found in live retail markets supplying the restaurant trade were examined for the presence of the SARS virus. SCoV-like viruses with 99.8% genetic homology with the SCoV were isolated from Himalayan or masked palm civets (Paguma larvata) and a raccoon dog (Nyctereutes procyonoides) and neutralizing antibody detected in them and a Chinese ferret badger (Melogale moschata) (29). The human and wild mammal isolates could be distinguished phylogenetically within the nucleotide polymorphism of the spike gene, the gene encoding the protein responsible for the virus's coronal appearance. These and other data strongly suggested that the human SCoV is unlikely to have been the product of a recent intercoronaviral, recombination event (30) given the propensity of coronaviruses to recombine (31), and that index infection was from an established animal virus resident in animals (29).

Just as pandemic influenza is now considered a noneradicable zoonosis, the question arises whether SARS is, too. This begets the central question whether the civet cat is the prime host of SCoV-like viruses and whether human infection was the result of an enzootic or epizootic. Much work now needs to be done to understand the ecology of the virus. Studies of this kind may provide insight into the extent and diversity of coronaviruses in the animal kingdom; studies, which over the next decade, will have the value-added effect of improved understanding of common cold coronaviruses and their likely control by antiviral agents.

While the domestication of the duck 4,500 years ago brought influenza viruses into the "farmyard", leading to the emergence of epidemics and pandemics (32), information of the involvement of wild, exotic mammals in the SARS outbreak as it presently stands (28, 29) suggests that outbreaks of SARS-like illness may have occurred in times past in the countryside. Such outbreaks may have been just as severe as the recent episode but probably would have died out because of limited opportunity for the virus to spread from village focal points. Bringing exotic mammals, presumably stressed and shedding increased levels of virus, into densely populated centers contrives an artificial setting ideal for exposing animal handlers and the public to the virus. Burgeoning national and international travel exposed the existence of the SARS disease and its causative agent.

It remains to be seen whether SARS has a parallel with pandemic influenza in which domestic animals act as an intermediate or amplifying host for viruses originating from the wild. Here, it should be noted that duck-raising practices were modified at the start of the Ching Dynasty (1644 A.D.) by moving the birds from river banks and tributaries onto flooded rice fields as an adjunct to rice farming. This beautifully balanced ecosystem led to a permanent gene pool of avian influenza viruses in southern China (and other parts of east Asia) in close proximity to humans (9, 32, 33). In city markets, the continuity of SARS-like and avian influenza viruses depends greatly on the mix of animals, their duration in the market, how they are held after trading, and hygienic handling practices. The worth of systematic virus surveillance as a preventative measure against pandemic influenza has been established (34). Now, surveillance will need to be vigorously pursued to define the ecology and the most important source(s) of SCoV-like virus(es) for humans to this end. This task may take some time. Basic studies on the nature and distribution of virus receptors in the intestinal and respiratory tracts of representative wild and domestic and domesticated animals may give an early guide to this task.

Given the diversity of coronaviruses in domestic animals and the demonstrated ability of some to recombine (31), the possibility exists that the host range and pathogenicity of the civet cat and raccoon dog SCoV-like viruses could alter should they recombine with other coronaviruses. Were an SCoV or SCoV-like virus to recombine with a human coronavirus, known or as-yet unidentified, changes in host range and pathogenicity of each virus might ensue. These are uncharted waters.

The association of southern China with the emergence of respiratory virus infections raises the question of why this is so. H5N1/97 virus, its precursor viruses H5N1, H9N2, H6N1, and H5N1-like viruses have been isolated from domestic poultry in the region (e.g., 5, 3537), and now there is the SCoV-like virus from the civet cat and raccoon dog (29). Live retail markets are the common denominator for this. Consequently, attention has focused on this type of market as a breeding ground for infections that affect humans (38). Chinese generally prefer food as fresh as possible. Taste is the prime consideration, thus meat should be from freshly killed animals. This particularly applies to poultry, giving rise to the existence of live-poultry markets. Poultry comprise two groups: major poultry, chicken, duck and goose, the chicken being the most important; and minor poultry, including pigeon, quail, pheasant, chukar, partridge, Guinea fowl, and waterfowl. Avian influenza viruses have been isolated from all of these birds.

The southern Chinese have a more marked preference for fresh food (of all kinds) nurtured particularly in the southeast corner by fertile land. Yet despite this, economic hardship persisted. Much of what was raised or grown was sold or traded, leaving poorer quality food for family consumption. The housewife ingeniously used all parts of an animal. Meat that was not produced had to be hunted, valued as much for its nutritive value as for its added taste. The scarcity (and seasonality) of such animals enhanced their value. There was also the belief that just as "like-healed-like," certain parts of the animal would enhance the human equivalent. For example, brains were cooked and given to scholars, feet/trotters were thought to enhance speed or other athletic performance, and so on. A main meat dish would only appear on the table for celebrations or feast days (39).

These traditions continue to the present, accounting for exotic food markets and, it appears, the SARS phenomenon. One of the intriguing aspects of the index case was that it occurred in mid-November (28), when snake meat and other snake parts are widely consumed to ward off the chills of the coming winter, raising the question of whether snakes are hosts to coronaviruses and what is the susceptibility of mammals, such as the civet cat, to infection by such viruses. The opportunity for exchange of viruses amongst different hosts, particularly from feces in cages, shop floors, holding pens, and killing rooms, would be considerable. Systematic virus surveillance of lower animals for coronaviruses is warranted.

Just as SARS investigations benefited from the ecologic studies on influenza viruses before it, so, too, influenza investigations stand to progress from the SARS experience. More than likely, the two fields will develop in tandem. It has often been said that influenza virologists should link hands with arbovirologists because of the overlapping interest in diverse nonhuman hosts. SARS investigations would benefit from this link, too, the spreading West Nile virus is a case in point (40). Such a conjoint relationship may offer a better prospect for infectious-disease intelligence (41). Although influenza-like viruses have been isolated from nonmammalian hosts (42, 43), probably more ecologically important is the recognition that a mammal, such as the mink, is susceptible to infection by the avian influenza virus H10N4 (44). On a personal note, the writer's interest in exploring animals as a source of pandemic influenza viruses was stirred by the detection of virus infectivity neutralizing activity for the reference H2N2 (Asian) influenza virus in the sera of two Asiatic black bears (Selenarctus thibetanus) and an orangutan (Pongo pygmaeus) obtained in the mid-1960s from a zoologic collection (45). Although it was not possible to know whether these animals had been infected in the wild or in the zoo (as was more likely), the fact that the bears were subsequently traced back to a zoologic gardens in Hong Kong and that the sera were examined in the wake of the 1968 H3N2 (Hong Kong) pandemic was compelling.

Perhaps the greatest enigma about influenza is that pandemics occur on a time scale measured in decades rather than in years. This is despite the inestimable number of avian influenza viruses in southern China and the close association between humans and domestic animals in the countryside, facilitating exposure, as well as their presence in stressed poultry in live, retail markets. The possibility of infection through contact with wild animals in the countryside and city markets cannot be overlooked. More than likely, infection in the countryside is not uncommon (33), indicating how little is known about the genetic and molecular factors involved in the genesis of a pandemic virus in spite of recent advances (e.g., 4648). While there may be only a limited number of hemagglutinin subtypes of virus with the hierarchic capabilities for sustained antigenic progression in humans (49), the odds for a subtype giving rise to a pandemic virus must be inordinately high.

The factors involved in the genesis of each pandemic virus are probably different. Thus, whereas the H5N1 virus must be the prime candidate for pandemicity at present (34, 50), unless these factors are in place, it is quite possible that another virus subtype could preempt it. Bearing in mind the awareness about H5N1, it would be a step forward if its incursions could be limited to brushfires (51, 52). Recent events in southern China have indicated that avian influenza H5N1 and H9N2 viruses can directly infect humans (4, 53, 54) without undergoing prior reassortment with a prevailing human influenza A virus, in which the pig acts as a genetic mammalian "mixing vessel" (55). Certain avian H9 influenza viruses in southern China are presently undergoing remarkable evolutionary changes as they move through aquatic and terrestrial poultry, resulting in changes that would seemingly facilitate human infection (36). The potential role of the pig in the genesis of a future pandemic virus cannot be underestimated. It hosts both avian H9N2 and human H3N2 viruses, and serologic evidence indicates its susceptibility to infection by avian H4, H5, and H9 viruses (56, 57). It is quite possible that had the H5N1/97 virus undergone prior reassortment in a pig, it could have given rise to a "full-blooded" pandemic virus at the outset with little or no warning, and the outcome would have been dramatically different.

Of recent respiratory virus incursions from southern China, influenza has an historic association with the region, whereas SARS apparently does not. This association linking China as a place of origin of influenza epidemics and pandemics goes back centuries (58), in keeping with a view in 1918 that "the great pandemics usually originated in the Far East, and gradually extended westward" (59). The first pandemic for which there is epidemiologically cogent data "narrowing" this down to southern China was that of 1889 (60). The pandemic that continues to arouse much interest is that of 1918, considered the deadliest in history, which was caused by an H1N1-like virus (61). This interest stems from a concern that a virus of the same order of potency could emerge in the future. Information on the genetic and molecular features responsible for this may be of prognostic value in examining avian and other influenza viruses in the influenza gene pool. At issue here is whether the 1918 virus arose from the gene pool in southern China (62). There are gaps in information, but it is the writer's view that the simple epidemiologic information available (63, 64) provides an indication that the virus may have arisen in southern China some years before 1918 (65). Outbreaks of influenza in Europe in 1916 are therefore of interest (66). The recognition of an incipient pandemic situation with the H5N1 virus in 1997 (8) and the isolation of H9N2 viruses from human cases in Hong Kong and China (54, 67) consolidate the importance of southern China as a region from which future pandemics might arise. Much effort in the influenza epicenter now needs to be directed toward getting ahead of the next pandemic virus. Surveillance of noisy objects for viruses might not be considered! (68).

It would be folly not to be aware of the possibility that an influenza pandemic could arise beyond the southern China epicenter. As recent pandemic viruses have been of the Eurasian lineage, avian influenza viruses on the Eurasian landmass, as well as in Africa and Australasia, may have a greater propensity for pandemicity than those of the North American lineage. The recent outbreak of highly pathogenic H7N7 influenza virus infection in chickens in The Netherlands, with cases of conjunctivitis and the death of a veterinarian, is of concern (69). The spread of H9N2 viruses mainly in chickens approaching panzootic proportions (70) indicates their potential for causing human disease beyond the epicenter. Influenza H6N2 viruses have recently been isolated from chickens in California whose H6 genes do not fit into clearly defined North American or Eurasian lineages, raising the question whether these (and perhaps other) Eurasian viruses are in the process of spreading to North America (71). Veterinary regulatory authorities and health authorities alike need to be aware of the wider dimensions of avian influenza viruses. The possibility of SARS emerging indigenously beyond southern China should not be overlooked. Surveillance of the civet cat, raccoon dog, and related animals for coronaviruses in and beyond China is of importance. This is particularly so in the case of the civet cat, which is raised commercially for the perfume industry.

In November 2002, the SARS genie escaped from the bottle in southern China. On July 5 2003, the WHO announced that, on available information, human chains of SCoV transmission appeared to have been broken globally (26). The question remains whether the genie has returned to the bottle. As respiratory virus infections are more prevalent in winter in temperate climates, the coming months could be a reasonable guide to the answer. Surveillance, surveillance, surveillance, clinically and virologically, as part of a wider initiative of infectious disease intelligence, holds the key to this answer for SARS and pandemic influenza, particularly in the southern China focus (41). As a backdrop to this question, the observation in one study in Hong Kong, that chronic hepatitis-B infection is an independent risk factor for progression to acute respiratory distress syndrome (22), warrants wider epidemiologic investigation. It remains to be seen whether the higher numbers of SARS cases in China, Taiwan, Singapore, and Hong Kong (25) are epidemiologically significant compared with the significance of hepatitis B in these places. Until the SCoV-like virus ecology is better understood, it will be important to minimize contact with exotic food animals (72) lest SARS makes a return in the short or long term (73).

The last thing the world needs is another problem. One of the many problems facing mankind is the continued existence of classical infectious diseases, including parasitic diseases and the emergence and reemergence of others over the last 30–40 years, with the prospect of more to come. There has been a zoonotic skew in recently emerged diseases—a trend that is likely to continue, largely due to human behavior (74). Introducing domestic and exotic animals into population centers artificially widens the human–wildlife continuum. On the plus side, smallpox has been eradicated (notwithstanding the holding of known reference stocks in two centers) and poliomyelitis stands to be eradicated within the decade. Pandemic influenza remains a noneradicable zoonosis, and SARS has made an unwelcome zoonotic incursion. It is as if nature will continue to test mankind, seemingly holding all the aces, in spite of the great advances in science and technology. It is the writer's view that mankind must take nature on board as an equal partner rather than as an adversary, the two working for the benefit of all, harnessing all that science and technology can facilitate. A world devoid of infectious diseases will be a great leap forward in human development.

The time is now ripe, particularly with the splendid collaboration and cooperation that were manifested during the SARS outbreak (16), for the Warring States conviction that "the best medicine is preventative medicine (1, 2) to complete the cycle of history" in China and for China to usher in a new era toward preventing the emergence of infectious respiratory virus diseases. Bridging gaps through an invigorated flowering in understanding and awareness and through the need to recognize, report, and react to untoward infectious respiratory (and other) diseases in China are paramount in this prevention and is dependent on sound political will (34). Such action will be beneficial for dealing with SARS should it recur and critical toward early preventative steps in handling a future influenza pandemic, the impact of which will surely be greater than that of SARS (75). Action of this kind stands to benefit not only China but the global community (76).

FOOTNOTES

Aspects of this article were presented at the annual scientific meeting of the Australian and New Zealand Societies for Microbiology, Auckland, New Zealand, September 28 to October 2, 2003.

Conflict of Interest Statement: K.F.S. has no declared conflict of interest.

Received in original form October 5, 2003; accepted in final form October 14, 2003

REFERENCES

  1. Needham J, Lu G-D. The origins of immunology. In: Sivan N, editor. Science and civilization in China. Biology and biological technology, Part VI: Medicine. Vol. 6. Cambridge: Cambridge University Press; 2000. p. 114–174.
  2. Needham J. China and the origins of immunology. Centre of Asian Studies occasional papers and monographs, No.41. Hong Kong: University of Hong Kong; 1980.
  3. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue H, Swayne D, Bender C, Huang J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998;279:393–396.[Abstract/Free Full Text]
  4. Claas ECJ, Osterhaus ADME, Vanbeek R, DeJong JC, Rimmelzwaan FG, Senne DA, Krauss S, Shortridge KF, Webster RG. Human influenza A (H5N1) virus related to a highly pathogenic avian influenza virus. Lancet 1998;351:472–477.[CrossRef][Medline]
  5. Yuen KY, Chan PKS, Peiris JSM, Tsang DNC, Que TL, Shortridge KF, Cheung PT, To WK, Ho ETF, Sung R, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467–471.[CrossRef][Medline]
  6. Guan Y, Peiris JS, Lipatov AS, Ellis TM, Dyrting KC, Krauss S, Zhang LJ, Webster RG, Shortridge KF. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci USA 2002;99:8950–8955.[Abstract/Free Full Text]
  7. Secretary for Environment and Food. Report of the investigation team for the 2002 avian influenza incident. Hong Kong: Government of the Hong Kong SAR, China; 2002. pp. 51+12 annexes.
  8. Shortridge KF, Gao P, Guan Y, Ito T, Kawaoka Y, Markwell D, Takada A, Webster RG. Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet Microbiol 2000;74:141–147.[CrossRef][Medline]
  9. Shortridge KF, Stuart-Harris CH. An influenza epicentre? Lancet 1982;ii:812–813.
  10. Webster RG, Laver WG. Antigenic variation of influenza viruses. In: Kilbourne ED, editor. The influenza viruses and influenza. New York: Academic Press; 1975. p.269–314.
  11. Shortridge KF. Pandemic influenza: a blueprint for control at source. Chin J Exp Clin Virol 1988;2:82–90.
  12. Stuart-Harris CH. Pandemic influenza: an unresolved problem in prevention. J Infect Dis 1970;122:108–115.[Medline]
  13. Peiris JSM, Lai ST, Poon LLM, Guan Y, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:319–325.[CrossRef]
  14. World Health Organization. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003;78:86.
  15. World Health Organization. Acute respiratory syndrome, China. Wkly Epidemiol Rec 2003;78:41.
  16. Stohr K. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730–1733.[CrossRef][Medline]
  17. Enserink M, Vogel G. Deferring competition, global net closes in on SARS. Science 2003;300:224–225.[Abstract/Free Full Text]
  18. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995–2003.[Abstract/Free Full Text]
  19. Ksiazek TG, Erdman D, Goldsmith C, Zaki SR, Peret T, Emery S, Tong SX, Urbani C, Comer JA, Lim W, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953–1966.[Abstract/Free Full Text]
  20. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H-R, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967–1976.[Abstract/Free Full Text]
  21. Ruan YJ, Chia LW, Ling AE, Vega VB, Thoreau H, Yun STS, Chia JM, Ng P, Chiu KP, Lim L, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779–1785.[CrossRef][Medline]
  22. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, Law KI, Tang BSF, Hon TYW, Chan CS, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated pneumonia: a prospective study. Lancet 2003;361:1767–1772.[CrossRef][Medline]
  23. Nicholls JM, Poon LLM, Lee KC, Ng WF, Lau ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773–1778.[CrossRef][Medline]
  24. World Health Organization. SARS: breaking the chains of transmission. http://www.who.int/features/2003/07/en (accessed July 25 2003).
  25. World Health Organization. Summary table of SARS cases by country, 1 November 2002–15 August 2003. http://www.who.int/csr/sars/country/2003_08_15/en (accessed September 8 2003).
  26. World Health Organization. SARS outbreak contained worldwide. http://www.who.int/mediacentre/releases/2003/pr56/en (accessed July 25 2003).
  27. World Health Organization. Alert, verification and public health management of SARS in the post-outbreak period. http://www.who.int.csr/sars/postoutbreak/en (accessed September 8 2003).
  28. Zhong NS, Zheng BJ, Li YM, Poon LLM, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet 2003;362:1353–1358.[CrossRef][Medline]
  29. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003;302:276–278.[Abstract/Free Full Text]
  30. Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, Khattra J, Asano JK, Barber SA, Chan SY, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399–1404.[Abstract/Free Full Text]
  31. Holmes KV. Coronaviruses. In: Knipe DM, Howley PM, editors. Fields virology, 4th edition. Philadelphia: Lippincott, Williams, and Wilkins; 2001. p.1187–1203.
  32. Shortridge KF. Is China an influenza epicentre? Chin Med J 1997;110:637–641.[Medline]
  33. Shortridge KF. Pandemic influenza: a zoonosis? Semin Respir Infect 1992;7:11–25.[Medline]
  34. Shortridge KF, Peiris JS, Guan Y. The next influenza pandemic: lessons from Hong Kong. J Appl Microbiol 2003;94 (Suppl):70–79
  35. Chin PS, Hoffmann E, Webby R, Webster RG, Guan Y, Peiris M, Shortridge KF. Molecular evolution of H6 influenza A viruses from poultry in southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97(H5N1)-like genes in poultry. J Virol 2002;76:507–516.[Abstract/Free Full Text]
  36. Li KS, Xu KM, Peiris JSM, Poon LLM, Yu KZ, Yuen KY, Shortridge KF, Webster RG, Guan Y. Characterization of H9 subtype influenza viruses from ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003;77:6988–6994.[Abstract/Free Full Text]
  37. Lui H, Cheng J, Peng D, Jia L, Zhang R, Liu X. Comparison of sequences of the hemagglutinin gene and phylogenetical analysis of H9 subtype avian influenza viruses isolated from some regions in China (In Chinese). J Microbiol 2002;42:288–297.
  38. Schafer S, Guterl F. How to make a virus. Newsweek International; April 21, 2003;CXLI:54–56.
  39. Chen YP. The altar and the table: field studies on the dietary culture of Chaoshan inhabitants. In: Wu DYH, Tan TC, editors. Changing chinese foodways in Asia. Hong Kong: the Chinese University Press; 2001. p. 19–34.
  40. Rappole JH, Hubalek Z. Migratory birds and the West Nile virus. J Appl Microbiol 2003;94:47–58.[CrossRef]
  41. Bonn D. Is SARS masking an influenza threat? Lancet Infect Dis 2003;3:401.[CrossRef]
  42. Mjaaland S, Rimstad E, Falk K, Dannevig BH. Genomic characterization of the virus causing infectious anaemia in Atlantic salmon (Salmo salar L.): an orthomyxo-like virus in a teleost. J Virol 1997;71:7681–7686.[Abstract]
  43. Cox NJ, Fuller F, Kaverin N, Klenk HD, Lamb RA, Mahy BWJ, et al. Orthomyxoviridae. In: van Regenmortel MHV, Fauquet CM, Bishop DHL, Carstens EB, Estes MK, Lemon SM, editors. Virus taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses, San Diego, CA. Academic Press; 2000. p. 585–97.
  44. Klingeborn B, Englund L, Rott R, Juntti N, Rockborn G. An avian influenza A virus killing a mammalian species—the mink. Arch Virol 1985;86:347–351.[CrossRef][Medline]
  45. Shortridge KF, Belyavin G, Bidwell DE. The occurrence of human influenza virus A antibodies in the sera of certain wild species of animal. Arch Gesamte Virusforsch 1970;32:286–290.[CrossRef][Medline]
  46. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2002;293:1840–1842.
  47. Shaw M, Cooper L, Xu X, Thompson W, Krauss S, Guan Y, Zhou N, Klimov S, Cox N, Webster RG, et al. Molecular changes associated with the transmission of influenza A H5N1 and H9N2 viruses to humans. J Med Virol 2002;66:107–14.[CrossRef][Medline]
  48. Perez D, Seiler JP, Guan Y, Peiris M, Shortridge KF, Webster RG. Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol 2003;77:3148–3156.[Abstract/Free Full Text]
  49. Shortridge KF, Underwood PA, King AP. Antigenic stability of H3 influenza viruses in the domestic duck population of southern China. Arch Virol 1990;114:121–136.[CrossRef][Medline]
  50. Shortridge KF, Peiris M, Guan Y, Dyrting K, Ellis T, Sims L. H5N1 virus: beaten but is it vanquished? In: Dodet B, Vicari M, editors. Symposium proceedings: emergence and control of zoonotic ortho- and paramyxovirus diseases. Paris: John Libbey Eurotext; 2001. p. 91–97.
  51. World Health Organization. Disease outbreak news: no further cases of human influenza A (H5N1) have been reported in Hong Kong SAR. http://www.who.int/csr/don/2003 02 27a/en (accessed February 27, 2003).
  52. Guan Y, Poon LLM, Yuen KY, Webster RG, Peiris JSM. The re-emergence of H5N1 influenza virus in humans: a renewal of pandemic concern? Options for the control of influenza V [abstract]. October 7–11, 2003. Okinawa, Japan. p. 52–53.
  53. Lin YP, Shaw M, Gregory V, Cameron K, Lim W, Klimov A, Subbarao K, Guan Y, Krauss S, Shortridge KF, et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci USA 2002;97:9654–9658.
  54. Gou YJ, Xie JP, Wang M, Dong J, Gou JF, Zhang H, Wu KY. A strain of influenza A H9N2 repeatedly isolated from a human population in China (In Chinese). Chin J Exp Clin Virol 2000;14:209–212.
  55. Scholtissek C, Burger H, Kistner O, Shortridge KF. The nucleoprotein as a possible factor in determining host range of influenza H3N2 viruses. Virology 1985;147:278–294.[CrossRef]
  56. Peiris JSM, Guan Y, Markwell D, Ghose P, Webster RG, Shortridge KF. Co-circulation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southern China: potential for genetic reassortment? J Virol 2002;75:9679–9686.
  57. Ninomiya A, Takada A, Okazaki K, Shortridge KF, Kida H. Seroepidemiological evidence of avian H4, H5, and H9 influenza A virus transmission to pigs in southeastern China. Vet Microbiol 2002;88:107–114.[CrossRef][Medline]
  58. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Oxford: Blackwell Science; 1998. p. 3–18.
  59. Anon. Epidemic influenza. JAMA 1918;71:1136–1137.
  60. Cantlie J. The first recorded appearance of the modern influenza epidemic. Brit Med J Aug 1891;29:491.
  61. Kilbourne ED. Influenza. New York: Plenum Medical Book Company; 1987.
  62. Reid AH, Taubenberger JK. The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol 2003;84:2285–2292.[Abstract/Free Full Text]
  63. Chun J. Influenza including its infection among pigs. Nat Med J China 1919;5:34–44.
  64. Cadbury WW. The 1918 pandemic of influenza in Canton. Chin Med J 1920;34:1–17.
  65. Shortridge KF. The 1918 "Spanish" flu: pearls from swine. Nat Med 1999;5:384–385.[CrossRef][Medline]
  66. Oxford JS, Sefton A, Jackson R, Innes W, Daniels RS, Johnson NPAS. Early herald wave outbreaks of influenza in 1916 prior to the pandemic of 1918. In:Osterhaus ADME, Cox N, Hampson AW, editors. Options for the control of influenza IV. Amsterdam: Elsevier Science; 2001. p. 155–161.
  67. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RWM, Orr WK, Shortridge KF. Human infection with influenza H9N2. Lancet 1999;354:916–917.[CrossRef][Medline]
  68. Anonymous. How influenza started in China! Far East Rev 1920;March:170.
  69. ProMED-mail. Confusion following doctor's death of fowl plague. http://www.nrc.nl/binnenland/artikel/1050989242911.html (accessed April 24, 2003).
  70. Alexander DJ. Ecology of influenza viruses in domestic birds. In: Dodet B, Vicari M, editors. Symposium proceedings: emergence and control of zoonotic ortho- and paramyxovirus diseases. Paris: John Libbey Eurotext; 2001. p. 25–33.
  71. Webby RJ, Woolcock PR, Krauss SL, Webster RG. Reassortment and interspecies transmission of North American H6N2 influenza viruses. Virology 2002;295:44–53.[CrossRef][Medline]
  72. Liu M. Return of a killer. Newsweek International 2003 http://www.msnbc.com/news/966386.asp (accessed 17 2003).
  73. Schwartz P. Future shock: the headlines of tomorrow. Esquire 2003; 112–115.
  74. Daszak P, Cunningham AA, Hyatt AD. Viral emergence in the human–wildlife continuum. In: Dodet B, Vicari M, editors. Symposium proceedings: emergence and control of zoonotic ortho- and paramyxovirus diseases. Paris: John Libbey Eurotext; 2001. p. 1–14.
  75. Shortridge KF. SARS exposed, pandemic influenza lurks (correspondence). Lancet 2003;361:1649.
  76. Emerging stronger from the China crisis (editorial). Lancet 2003;361:1311.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
J. J. Dennehy, N. A. Friedenberg, Y. W. Yang, and P. E. Turner
Bacteriophage Migration via Nematode Vectors: Host-Parasite-Consumer Interactions in Laboratory Microcosms.
Appl. Envir. Microbiol., March 1, 2006; 72(3): 1974 - 1979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 239 - 253.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shortridge, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shortridge, K. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society